Skip to main content

Table 5 Doses for common treatment sites and organs at risk reported in RSSearchâ„¢

From: The RSSearchâ„¢ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy

Treated organ

Organs at risk

Median volume (range), cc

Median # fractions (range)

Median dose (range), Gy

Median max point dose (range), Gy

Brain

 

3.3 (< 1 – 804)

1 (1 – 25)

24 (2 – 96)

30 (0 – 96)

 

Brain stem

   

5 (0 – 70)

 

Eye/lens

   

0.4 (0 – 70)

 

Optic chiasm

   

2 (0 – 51)

 

Optic nerve

   

1 (0 – 41)

Lung/bronchus

 

14 (0.2 – 1751)

3 (1 – 10)

54 (11 – 80)

71 (0 – 100)

 

Esophagus

   

11 (0 – 63)

 

Heart

   

14 (0 – 64)

 

Trachea/bronchus

   

12 (0 – 76)

 

Spinal cord

   

7 (< 1– 76)

Liver

 

32 (1– 877)

3 (1– 5)

45 (10 – 60)

58 (12 – 94)

 

Uninvolved liver

   

60 (18 – 75)

 

Bowel

   

17 (0 – 66)

 

Kidney

   

6 (0 – 64)

 

Spinal cord

   

4 (0 – 17)

Pancreas

 

34 (2 – 172)

3 (1 – 5)

29 (2 – 60)

38 (0 – 73)

 

Bowel

   

24 (0 – 56)

 

Kidney

   

5 (0 – 27)

 

Liver

   

22 (2 – 70)

 

Spinal cord

   

4 (0 – 13)

Prostate

 

56 (6 – 296)

5 (1– 38)

36.25 (6.5 – 80)

48 (9 – 86)

 

Bladder

   

41 (0.5 – 80)

 

Femoral heads

   

14 (0.5 – 111)

 

Penile bulb

   

27 (0.7 – 66)

 

Rectum

   

38 (6 – 78)

 

Urethra

   

43 (8 – 83)